KONINKLIJKE PHILIPS NV
KONINKLIJKE PHILIPS NV is a Healthcare company operating in Medical Devices with a $25.08B market cap.
Behavioral analysis
Disclosures
Transcripts
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Spoken Alpha tracks RYLPF's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SamplePeers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for RYLPF.
$ curl https://api.spokenalpha.com/v1/companies/RYLPFFAQ
Spoken Alpha indexes RYLPF's earnings call transcripts at https://spokenalpha.com/companies/RYLPF. Each call links to attributed speakers and parsed analyst Q&A.
KONINKLIJKE PHILIPS NV (RYLPF) operates in the Healthcare sector (Medical Devices industry).
Repeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $2.37 | $2.96 | -19.8% | +1.7% | +3.3% |
| Q4 FY2026 | $2.25 | $2.81 | -19.8% | +2.8% | +5.1% |
| Q3 FY2026 | $2.43 | $2.93 | -16.9% | +0.3% | +1.0% |
| Q2 FY2026 | $2.31 | $3.04 | -23.9% | -0.3% | +1.0% |
| Q1 FY2025 | $2.49 | $2.93 | -14.9% | -0.7% | +1.4% |
| Q4 FY2025 |
| $2.13 |
| $2.91 |
| -26.7% |
| +2.3% |
| +1.2% |
| Q3 FY2025 | $2.34 | $2.98 | -21.6% | +3.5% | +5.4% |
| Q2 FY2025 | $2.57 | $3.02 | -14.9% | -2.7% | +0.3% |
| Q1 FY2024 | $2.30 | $3.05 | -24.7% | +1.7% | +4.7% |
| Q4 FY2024 | $2.41 | $3.06 | -21.2% | -2.4% | -1.3% |